Miriam Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity
Miriam Kidron is Chief Scientific Officer of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 1.43 Million shares of ORMP, which is worth approximately $3.4 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 236,331 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.43M
19.8%
3M change
42.87%
12M change
Total Value Held
$3.4 Million
Miriam Kidron Transaction History
MK
Miriam Kidron
Chief Scientific Officer
Jerusalem, L3